Detection of hemizygous deletions in genomic DNA from leukaemia specimens for the diagnosis of patients

Ursula Kees, P.A. Terry, J. Ford, J. Everett, A. Murch, Nicholas De Klerk, D.L. Baker

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Hemizygous deletions in genomic DNA appear to play an important role in tumorigenesis. The loss or inactivation of tumour suppressor genes (TSGs) is of critical importance in most malignancies, and has been shown to affect response to therapy. Here, we report a quantitative real-time polymerase chain reaction (qPCR) designed to detect two TSGs at the CDKN2A locus, p16(INK4A) and p14(ARF) that allows the detection of hemizygous deletions. Testing by qPCR of 18 bone marrow specimens from paediatric acute lymphoblastic leukaemia (ALL) patients at diagnosis revealed nine to be GG, six to be GD and three to be DD for exon 2 of p14(ARF)/p16(INK4A) concordant with Southern blotting analysis. A panel of 13 ALL cell lines was investigated for deletions at the CDKN2A locus and one of the lines, typed as GD for all exons, was further assessed by fluorescence in situ hybridisation, confirming the qPCR findings. The expression levels of p16(INK4A) and p14(ARF) were measured in all cell lines and these quantitative reverse transcriptase PCR results also agreed with the typing by qPCR. The qPCR method described is suitable for detection of hemizygous loss in primary patient material and the accuracy of the method was verified by three independent techniques. (C) 2004 Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)165-71
JournalLeukemia Research
Issue number2
Publication statusPublished - 2005


Dive into the research topics of 'Detection of hemizygous deletions in genomic DNA from leukaemia specimens for the diagnosis of patients'. Together they form a unique fingerprint.

Cite this